BGPT: Visualize Data: RAD51 foci induction Type I Type II after DNA damage

Explore by Goal

Quick Analysis Plan Copied

Goal

Build an analysis + visualization workflow that takes RAD51 foci induction data and produces Type-I vs Type-II comparisons (and optionally kinetics) after DNA damage—grounded in how RAD51 foci quantify HR activation across perturbations.

Uses the common experimental logic: RAD51 foci quantification as an HR-associated marker after DNA damage, and how perturbations (e.g., RAD51 mutants, RAD51 regulators) shift foci/foci-positive fraction and repair phenotypes.

Long Analysis Plan

RAD51 foci induction: Type I vs Type II after DNA damage

Scientific output: (1) robust data schema, (2) normalization choices, (3) statistical tests, (4) Plotly figures (induction, kinetics, and Type-I/Type-II composition).

1) What “Type I vs Type II” should mean (you must define it)

“Type I/Type II” is not a universal RAD51-foci standard in the provided sources, so you should operationalize it from your microscopy features (examples: size, intensity, counts per nucleus, colocalization with γH2AX, or appearance pattern over time). A key skepticism point: RAD51 “foci” can reflect different molecular assemblies/contexts; foci quantification is informative but can be correlative without orthogonal HR/resection/restart readouts.

Minimum feature set for type-calling

Per nucleus: total RAD51 foci count, fraction RAD51+ nuclei, per-foci intensity/area (distributions).
Per foci: area (px²), integrated intensity, maximum intensity, circularity/texture.
Optional DDR coupling: γH2AX foci presence (or intensity) and RAD51/γH2AX overlap.
Kinetics: timepoint (e.g., 0/2/4/8h) and DNA damage agent identity/dose.

2) Data schema (what you store before plotting)

Level	Required fields	Purpose
Experiment	dataset_id, cell_line, genotype, damage_agent, dose, timepoint, fixation/staining_batch	Group context + reproducible filtering
Nucleus (per cell)	nucleus_id, rad51_positive (0/1), rad51_total_foci, rad51_foci_area_sum, rad51_mean_intensity	Fraction-positive and per-cell induction metrics
Foci (per object)	foci_id, nucleus_id, foci_type (I/II), area, intensity, overlap_gammaH2AX (0/1), distance_to_nucleolus (optional)	Type composition and size/intensity distributions

RAD51 foci quantification is widely used; e.g., studies report changes in RAD51 foci per cell or the percentage of RAD51-positive cells after X-ray or replication stress.

3) Normalization & summary metrics (define before statistics)

Induction: compare each condition vs its matched control (same cell line/genotype/batch):
- Foci-positive fraction: p = (# RAD51+ nuclei) / (total nuclei)
- Mean foci per nucleus (or per RAD51+ nucleus) depending on your biological question
Type composition (crucial for your Type I/II question):
- Type I fraction among all RAD51 foci: f_I = N_I / (N_I + N_II)
- Type-specific per-cell burden: N_I per nucleus and N_II per nucleus
Kinetics: plot timepoint-resolved induction curves; avoid mixing timepoints in a single bar figure.

Counterpoint: if Type I/II are derived from intensity/size thresholds, batch effects can dominate; therefore you should include batch as a blocking variable or standardize thresholds using negative/vehicle controls within each batch.

4) Statistics (skeptical, assumption-aware)

Use a model that respects per-cell counts (binomial for RAD51+ fraction; negative binomial / zero-inflated if you have many zero nuclei for foci counts). Keep replicates independent.

RAD51+ fraction (Type-agnostic): hierarchical binomial with replicate as random effect.
Per-cell foci: negative binomial GLM (or median comparisons if distributions are highly non-normal).
Type composition per cell: model N_I and N_II jointly (multinomial/Dirichlet-multinomial) or treat foci-level as objects with clustered errors.
Multiple testing: control FDR across timepoints/conditions.

5) Plotly figures (grounded in provided numeric examples)

Below, I include only figures I can populate from the provided research excerpts. If your own dataset contains Type I/Type II labels, you will extend these plots using your raw data.

This is an example visualization using the provided numeric excerpt for RAD51 foci-positive fractions under CPT sensitivity experiments in Swsap1-/- vs WT.

The provided excerpt shows that RAD51-II3A can preserve RAD51 foci yet fails to robustly restore HR reporter activity, motivating why Type I/II foci should be interpreted together with HR function readouts.

Type I/II composition is computed from your microscopy segmentation outputs (N_I and N_II). The underlying interpretive caution—that foci alone may not fully predict HR function—is supported by RAD51-II3A vs WT HR reporter differences.

6) Optional: incorporate DDR/repair pathway context (how to enrich interpretation)

If your Type I/II definitions include overlap with γH2AX, you can interpret RAD51 dynamics in the broader DSB repair context. For example, perturbing HR/NHEJ regulators can shift RAD51 recruitment patterns and foci intensities.

7) Edge cases & scientific blindspots (must check)

Segmentation threshold drift across batches/timepoints can artificially create “Type I/II” separation.
Correlation vs causation: RAD51 foci are a marker; functional HR/restart assays are needed for mechanistic claims.
Agent mismatch: RAD51 foci induction differs by DNA damage modality and cell-cycle state; compare matched experimental conditions.
Missing definition: Type I vs II must be explicitly reproducible (criteria + code + thresholds).

8) Practical coding workflow (what you’ll implement)

Ingest your nucleus/foci tables (CSV/Parquet) into a single tidy format.
Compute per-nucleus metrics: rad51_positive, total foci, intensity summaries.
Type-calling: assign foci_type (I/II) from your feature thresholds (or clustering trained on controls).
Aggregate per condition/timepoint/replicate:
- Fraction positive p
- Mean foci per nucleus
- Type I/II counts and fractions
Plot with Plotly:
- Bar/point plots: induced p vs control
- Stacked composition: f_I vs timepoint
- Violin/ECDF: foci intensity/area distributions by type
Stats: run replicate-aware tests; export effect sizes + CIs.
Report a reproducible “foci-type definition” section (thresholds, quality control plots, batch corrections).

Next step (optional)

If you upload your raw per-nucleus and per-foci data (or screenshots + exported segmentation measurements), BGPT can compute Type I/II induction curves and generate publication-ready Plotly panels.

Feedback:

Updated: March 26, 2026

Top Data Sources Export MCP

1. The Arabidopsis homolog of mammalian AATF/Che-1, AtCHE1, is essential for root meristem maintenance and genome stability, functioning in the plant DNA damage response pathway and genetically interacting with SOG1 and ATR to safeguard genome integrity. [2025]

9QualityResults Limitations Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

2. The study identifies C8orf33 as a regulator of DNA double-strand break repair choice in human cells by antagonizing KAT8-mediated H4K16 acetylation, thereby promoting NHEJ via 53BP1 recruitment and limiting HR, with nucleolar rDNA stability implications and potential cancer therapy relevance. [2025]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

3. HSV-1 replication compartments recruit host homologous recombination proteins RPA, RAD51, and NBS1 to prereplicative sites in a polymerase-dependent manner, correlating with activation of a DNA damage response, while Ku86 is excluded; four-protein subassemblies recapitulate HR protein recruitment to UL29-associated foci, implying HR involvement in early HSV-1 DNA replication and concatemer formation. [2004]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

4. Pomegranate extract inhibits growth of MCF-7 breast cancer cells by downregulating DNA repair genes—especially homologous recombination pathway components—leading to increased double-strand breaks, with upregulation of miR-183 and miR-24 suggesting a microRNA–mediated mechanism that is not solely due to antioxidant activity. [2013]

8QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

5. SWSAP1 promotes RAD51 filament assembly by counteracting the anti-recombinase FIGNL1, thereby safeguarding DNA repair and meiotic recombination; loss of SWSAP1 impairs RAD51 assembly and genome stability, which can be rescued by depleting FIGNL1. [2019]

9QualityResults Limitations Context Blindspots Methods Sample Conflict Data

↗ Paper Review ↗ Full Paper

Key Insight

RAD51 foci readouts can separate from HR function: a RAD51 state may preserve foci yet fail strand-exchange-mediated repair, so Type I/II likely encodes “assembly mode,” and must be validated against HR or fork restart phenotypes rather than assumed equivalent to functional HR.

Keep Exploring

Which microscopy features (area, intensity, γH2AX overlap, spatial localization) best disentangle two mechanistic RAD51 states in your dataset, and how do you justify the Type I/II boundary objectively?

Does the Type I→Type II conversion rate predict HR reporter outcomes or fork restart metrics better than endpoint total RAD51 foci—and how do you test that rigorously?

How do RAD51 Type distributions change across damage modalities (crosslinks vs replication stress vs DSB-inducing agents) and does the same Type definition remain valid?

Analysis Wizard

Compute per-condition RAD51+ fraction, total foci per nucleus, and Type I/II composition from your nucleus/foci tables; then generate induction and kinetics Plotly panels and replicate-aware effect-size statistics.

Hypothesis Graveyard

If Type I/II are only intensity-threshold artifacts of imaging exposure, then changing exposure/threshold will swap Type labels without changing HR function—making Type composition non-biological; this is rejected by requiring threshold-stable classification across batches.

If Type I/II differ only in foci size but not in overlap with functional readouts (HR reporter, restart assays), then the Type classifier is not mechanistically informative and should be replaced by a simpler metric (total RAD51+ fraction or mean per cell).

Potential Experiments

Perform a threshold-stability audit: vary segmentation/intensity thresholds within a validated range and test whether Type I/II composition changes correlate with HR reporter shifts; a biologically meaningful Type split should remain stable and track function.

Time-resolved Type conversion assay: after a fixed DNA damage dose, quantify RAD51 Type I and Type II composition at multiple timepoints and test whether the Type II fraction rise rate predicts HR reporter efficiency more strongly than total RAD51 foci at any single endpoint.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I prioritize evidence that links foci quantification to functional HR outcomes, so purely descriptive imaging-first plans get tempered unless orthogonal readouts exist in the data.

Stay current without chasing every paper.

Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Top Data Sources Export MCP

1. The Arabidopsis homolog of mammalian AATF/Che-1, AtCHE1, is essential for root meristem maintenance and genome stability, functioning in the plant DNA damage response pathway and genetically interacting with SOG1 and ATR to safeguard genome integrity. [2025]

5. SWSAP1 promotes RAD51 filament assembly by counteracting the anti-recombinase FIGNL1, thereby safeguarding DNA repair and meiotic recombination; loss of SWSAP1 impairs RAD51 assembly and genome stability, which can be rescued by depleting FIGNL1. [2019]

11. DNA binding by RAD51 is sufficient to protect and remodel stalled replication forks, while RAD51's strand exchange activity is required for efficient restart after prolonged replication stress, revealing distinct enzymatic and non-enzymatic roles for RAD51 at forks. [2019]

Ask a Follow-Up

Key Insight

RAD51 foci readouts can separate from HR function: a RAD51 state may preserve foci yet fail strand-exchange-mediated repair, so Type I/II likely encodes “assembly mode,” and must be validated against HR or fork restart phenotypes rather than assumed equivalent to functional HR.

Keep Exploring

Which microscopy features (area, intensity, γH2AX overlap, spatial localization) best disentangle two mechanistic RAD51 states in your dataset, and how do you justify the Type I/II boundary objectively?

Does the Type I→Type II conversion rate predict HR reporter outcomes or fork restart metrics better than endpoint total RAD51 foci—and how do you test that rigorously?

How do RAD51 Type distributions change across damage modalities (crosslinks vs replication stress vs DSB-inducing agents) and does the same Type definition remain valid?

Analysis Wizard

Compute per-condition RAD51+ fraction, total foci per nucleus, and Type I/II composition from your nucleus/foci tables; then generate induction and kinetics Plotly panels and replicate-aware effect-size statistics.

Hypothesis Graveyard

If Type I/II are only intensity-threshold artifacts of imaging exposure, then changing exposure/threshold will swap Type labels without changing HR function—making Type composition non-biological; this is rejected by requiring threshold-stable classification across batches.

If Type I/II differ only in foci size but not in overlap with functional readouts (HR reporter, restart assays), then the Type classifier is not mechanistically informative and should be replaced by a simpler metric (total RAD51+ fraction or mean per cell).

Potential Experiments

Perform a threshold-stability audit: vary segmentation/intensity thresholds within a validated range and test whether Type I/II composition changes correlate with HR reporter shifts; a biologically meaningful Type split should remain stable and track function.

Time-resolved Type conversion assay: after a fixed DNA damage dose, quantify RAD51 Type I and Type II composition at multiple timepoints and test whether the Type II fraction rise rate predicts HR reporter efficiency more strongly than total RAD51 foci at any single endpoint.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I prioritize evidence that links foci quantification to functional HR outcomes, so purely descriptive imaging-first plans get tempered unless orthogonal readouts exist in the data.

Stay current without chasing every paper.

My BGPT

Trending

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Explore by Goal

Quick Analysis Plan Copied

Long Analysis Plan

Top Data Sources ExportMCP

1. The Arabidopsis homolog of mammalian AATF/Che-1, AtCHE1, is essential for root meristem maintenance and genome stability, functioning in the plant DNA damage response pathway and genetically interacting with SOG1 and ATR to safeguard genome integrity. [2025]

5. SWSAP1 promotes RAD51 filament assembly by counteracting the anti-recombinase FIGNL1, thereby safeguarding DNA repair and meiotic recombination; loss of SWSAP1 impairs RAD51 assembly and genome stability, which can be rescued by depleting FIGNL1. [2019]

11. DNA binding by RAD51 is sufficient to protect and remodel stalled replication forks, while RAD51's strand exchange activity is required for efficient restart after prolonged replication stress, revealing distinct enzymatic and non-enzymatic roles for RAD51 at forks. [2019]

Ask a Follow-Up

Key Insight

RAD51 foci readouts can separate from HR function: a RAD51 state may preserve foci yet fail strand-exchange-mediated repair, so Type I/II likely encodes “assembly mode,” and must be validated against HR or fork restart phenotypes rather than assumed equivalent to functional HR.

Keep Exploring

Which microscopy features (area, intensity, γH2AX overlap, spatial localization) best disentangle two mechanistic RAD51 states in your dataset, and how do you justify the Type I/II boundary objectively?

Does the Type I→Type II conversion rate predict HR reporter outcomes or fork restart metrics better than endpoint total RAD51 foci—and how do you test that rigorously?

How do RAD51 Type distributions change across damage modalities (crosslinks vs replication stress vs DSB-inducing agents) and does the same Type definition remain valid?

Analysis Wizard

Compute per-condition RAD51+ fraction, total foci per nucleus, and Type I/II composition from your nucleus/foci tables; then generate induction and kinetics Plotly panels and replicate-aware effect-size statistics.

Hypothesis Graveyard

If Type I/II are only intensity-threshold artifacts of imaging exposure, then changing exposure/threshold will swap Type labels without changing HR function—making Type composition non-biological; this is rejected by requiring threshold-stable classification across batches.

If Type I/II differ only in foci size but not in overlap with functional readouts (HR reporter, restart assays), then the Type classifier is not mechanistically informative and should be replaced by a simpler metric (total RAD51+ fraction or mean per cell).

Potential Experiments

Perform a threshold-stability audit: vary segmentation/intensity thresholds within a validated range and test whether Type I/II composition changes correlate with HR reporter shifts; a biologically meaningful Type split should remain stable and track function.

Time-resolved Type conversion assay: after a fixed DNA damage dose, quantify RAD51 Type I and Type II composition at multiple timepoints and test whether the Type II fraction rise rate predicts HR reporter efficiency more strongly than total RAD51 foci at any single endpoint.

Science Art

Science Movie

Make a narrated HD Science movie for this answer ($32 per minute)

Discussion

BGPT Bias

I prioritize evidence that links foci quantification to functional HR outcomes, so purely descriptive imaging-first plans get tempered unless orthogonal readouts exist in the data.

Stay current without chasing every paper.

My BGPT

Trending

Top Data Sources Export MCP